Optimata offers a first-of-its-kind treatment personalization tool for cancer diseases.
Expert in predictive biosimulation, Optimata mathematically models patient physiological and pathological processes, along with the dynamics of drug-patient interactions, putting a special focus on cancer and oncology drugs.
Simulated by Optimata Virtual Patient® and Predicare™ software, these models provide valuable predictions of drug effect , with recommendations of optimal treatment regimens for the patient and patient population.
Optimata's Virtual Patient® enables:
Enhanced drug competitive profile
Early "GO/NO-GO" development decisions
Drug safety profile
Optimal dosing schedules
Clinical indication selection/expansion
Optimata offers a powerful, interactive, clinical trial optimization tool, enabling huge reductions in time-to-market and development costs.